Arie Belldegrun - Sep 14, 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Sep 14, 2022
Transactions value $
$800,000
Form type
4
Date filed
9/16/2022, 03:13 PM
Previous filing
Sep 2, 2022
Next filing
Mar 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $800K +160K +64.34% $5.00 409K Sep 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -160K -100% $0.00* 0 Sep 14, 2022 Ordinary Shares 160K $5.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.